Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,940
+$12,220 QoQ
Shares Held
26,000
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 130 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST MANHATTAN CO. LLC. holds $1,927,732 across 8 Biotechnology names. OVID ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,560 | $774,898 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
11,146 | $394,456 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
43,500 | $296,235 | |
| 4 | IMRX |
Immuneering Corp
|
24,245 | $120,982 | |
| 5 | IOVA |
Iovance Biotherapeutics, Inc.
|
27,998 | $116,471 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 | |
| 7 | OVID |
Ovid Therapeutics Inc.
This page
|
26,000 | $69,940 | |
| 8 | ABUS |
Arbutus Biopharma Corp
|
14,000 | $67,200 |
All Filings in OVID
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,940 | 26,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $57,720 | 26,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,380 | 26,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,800 | 26,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,580 | 26,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,112 | 26,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $24,284 | 26,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,680 | 26,000 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $79,300 | 26,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $83,720 | 26,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $99,840 | 26,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $85,280 | 26,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $67,080 | 26,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $48,360 | 26,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $47,840 | 26,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,900 | 26,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $81,640 | 26,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $25,680 | 8,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $87,360 | 26,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $101,660 | 26,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $72,360 | 18,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $41,580 | 18,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $103,320 | 18,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $132,660 | 18,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $53,640 | 18,000 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||